09:47 AM EST, 11/27/2024 (MT Newswires) -- Natera ( NTRA ) said Wednesday its Prospera Lung test has obtained coverage from the Centers for Medicare & Medicaid Services for single lung transplant recipients in the surveillance setting.

The company said the Prospera Lung test first obtained Medicare coverage for double-lung transplant patients in 2023.

Price: 167.98, Change: -0.34, Percent Change: -0.20